Literature DB >> 21697338

Multisite comparison of high-sensitivity multiplex cytokine assays.

Elizabeth Crabb Breen1, Sandra M Reynolds, Christopher Cox, Lisa P Jacobson, Larry Magpantay, Candice B Mulder, Oliver Dibben, Joseph B Margolick, Jay H Bream, Elise Sambrano, Otoniel Martínez-Maza, Elizabeth Sinclair, Persephone Borrow, Alan L Landay, Charles R Rinaldo, Philip J Norris.   

Abstract

The concentrations of cytokines in human serum and plasma can provide valuable information about in vivo immune status, but low concentrations often require high-sensitivity assays to permit detection. The recent development of multiplex assays, which can measure multiple cytokines in one small sample, holds great promise, especially for studies in which limited volumes of stored serum or plasma are available. Four high-sensitivity cytokine multiplex assays on a Luminex (Bio-Rad, BioSource, Linco) or electrochemiluminescence (Meso Scale Discovery) platform were evaluated for their ability to detect circulating concentrations of 13 cytokines, as well as for laboratory and lot variability. Assays were performed in six different laboratories utilizing archived serum from HIV-uninfected and -infected subjects from the Multicenter AIDS Cohort Study (MACS) and the Women's Interagency HIV Study (WIHS) and commercial plasma samples spanning initial HIV viremia. In a majority of serum samples, interleukin-6 (IL-6), IL-8, IL-10, and tumor necrosis factor alpha were detectable with at least three kits, while IL-1β was clearly detected with only one kit. No single multiplex panel detected all cytokines, and there were highly significant differences (P < 0.001) between laboratories and/or lots with all kits. Nevertheless, the kits generally detected similar patterns of cytokine perturbation during primary HIV viremia. This multisite comparison suggests that current multiplex assays vary in their ability to measure serum and/or plasma concentrations of cytokines and may not be sufficiently reproducible for repeated determinations over a long-term study or in multiple laboratories but may be useful for longitudinal studies in which relative, rather than absolute, changes in cytokines are important.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21697338      PMCID: PMC3147360          DOI: 10.1128/CVI.05032-11

Source DB:  PubMed          Journal:  Clin Vaccine Immunol        ISSN: 1556-679X


  32 in total

1.  Effect of highly active antiretroviral therapy on biomarkers of B-lymphocyte activation and inflammation.

Authors:  Deborah L Regidor; Roger Detels; Elizabeth C Breen; Daniel P Widney; Lisa P Jacobson; Frank Palella; Charles R Rinaldo; Jay H Bream; Otoniel Martínez-Maza
Journal:  AIDS       Date:  2011-01-28       Impact factor: 4.177

2.  Validation and comparison of two multiplex technologies, Luminex and Mesoscale Discovery, for human cytokine profiling.

Authors:  Ferdousi Chowdhury; Anthony Williams; Peter Johnson
Journal:  J Immunol Methods       Date:  2008-11-05       Impact factor: 2.303

3.  Quantitative validation and comparison of multiplex cytokine kits.

Authors:  Joanna L Richens; Richard A Urbanowicz; Rebecca Metcalf; Jonathan Corne; Paul O'Shea; Lucy Fairclough
Journal:  J Biomol Screen       Date:  2010-02-22

4.  Correlation between plasma levels of cytokines and HIV-1 RNA copy number in HIV-infected patients.

Authors:  G Hittinger; C Poggi; E Delbeke; N Profizi; A Lafeuillade
Journal:  Infection       Date:  1998 Mar-Apr       Impact factor: 3.553

5.  Elevations in IL-10, TNF-alpha, and IFN-gamma from the earliest point of HIV Type 1 infection.

Authors:  Philip J Norris; Brandee L Pappalardo; Brian Custer; Gerald Spotts; Frederick M Hecht; Michael P Busch
Journal:  AIDS Res Hum Retroviruses       Date:  2006-08       Impact factor: 2.205

6.  Induction of a striking systemic cytokine cascade prior to peak viremia in acute human immunodeficiency virus type 1 infection, in contrast to more modest and delayed responses in acute hepatitis B and C virus infections.

Authors:  Andrea R Stacey; Philip J Norris; Li Qin; Elizabeth A Haygreen; Elizabeth Taylor; John Heitman; Mila Lebedeva; Allan DeCamp; Dongfeng Li; Douglas Grove; Steven G Self; Persephone Borrow
Journal:  J Virol       Date:  2009-01-28       Impact factor: 5.103

7.  Increased levels of inflammatory chemokines in amyotrophic lateral sclerosis.

Authors:  J Kuhle; R L P Lindberg; A Regeniter; M Mehling; A J Steck; L Kappos; A Czaplinski
Journal:  Eur J Neurol       Date:  2009-02-19       Impact factor: 6.089

8.  Inflammation and hemostasis biomarkers for predicting stroke in postmenopausal women: the Women's Health Initiative Observational Study.

Authors:  Robert C Kaplan; Aileen P McGinn; Alison E Baird; Susan L Hendrix; Charles Kooperberg; John Lynch; Daniel M Rosenbaum; Karen C Johnson; Howard D Strickler; Sylvia Wassertheil-Smoller
Journal:  J Stroke Cerebrovasc Dis       Date:  2008 Nov-Dec       Impact factor: 2.136

Review 9.  Multifactorial nature of human immunodeficiency virus disease: implications for therapy.

Authors:  A S Fauci
Journal:  Science       Date:  1993-11-12       Impact factor: 47.728

10.  An evaluation of commercial fluorescent bead-based luminex cytokine assays.

Authors:  Joel Fleury Djoba Siawaya; Teri Roberts; Chantal Babb; Gillian Black; Hawa Jande Golakai; Kim Stanley; Nchinya Bennedict Bapela; Eileen Hoal; Shreemanta Parida; Paul van Helden; Gerhard Walzl
Journal:  PLoS One       Date:  2008-07-02       Impact factor: 3.240

View more
  75 in total

1.  Salivary C-reactive protein among at-risk adolescents: A methods investigation of out of range immunoassay data.

Authors:  E R Landau; J Trinder; J G Simmons; M Raniti; M Blake; J M Waloszek; L Blake; O Schwartz; G Murray; N B Allen; M L Byrne
Journal:  Psychoneuroendocrinology       Date:  2018-09-08       Impact factor: 4.905

2.  Multiplexing and Beyond in Biobehavioral Research.

Authors:  Paul J Mills; Christine T Peterson
Journal:  Psychosom Med       Date:  2016 Jul-Aug       Impact factor: 4.312

3.  Validation of a multiplex electrochemiluminescent immunoassay platform in human and mouse samples.

Authors:  J A Bastarache; T Koyama; N E Wickersham; L B Ware
Journal:  J Immunol Methods       Date:  2014-04-21       Impact factor: 2.303

Review 4.  Exhaled breath condensate: an overview.

Authors:  Michael D Davis; Alison Montpetit; John Hunt
Journal:  Immunol Allergy Clin North Am       Date:  2012-07-20       Impact factor: 3.479

5.  Inflammatory Proteins Predict Change in Depressive Symptoms in Male and Female Adolescents.

Authors:  Daniel P Moriarity; Naoise Mac Giollabhui; Lauren M Ellman; Joshua Klugman; Christopher L Coe; Lyn Y Abramson; Lauren B Alloy
Journal:  Clin Psychol Sci       Date:  2019-03-01

6.  Immunocognitive Model of Depression Secondary to Anxiety in Adolescents.

Authors:  Daniel P Moriarity; Brae Anne McArthur; Lauren M Ellman; Christopher L Coe; Lyn Y Abramson; Lauren B Alloy
Journal:  J Youth Adolesc       Date:  2018-08-07

7.  Effects of serum and plasma matrices on multiplex immunoassays.

Authors:  Yael Rosenberg-Hasson; Leo Hansmann; Michaela Liedtke; Iris Herschmann; Holden T Maecker
Journal:  Immunol Res       Date:  2014-05       Impact factor: 2.829

8.  A comparison of biofluid cytokine markers across platform technologies: Correspondence or divergence?

Authors:  K B Casaletto; F M Elahi; R Fitch; S Walters; E Fox; A M Staffaroni; B M Bettcher; H Zetterberg; A Karydas; J C Rojas; A L Boxer; J H Kramer
Journal:  Cytokine       Date:  2018-06-14       Impact factor: 3.861

Review 9.  Cytokine aberrations in autism spectrum disorder: a systematic review and meta-analysis.

Authors:  A Masi; D S Quintana; N Glozier; A R Lloyd; I B Hickie; A J Guastella
Journal:  Mol Psychiatry       Date:  2014-06-17       Impact factor: 15.992

10.  Multiplex assay reliability and long-term intra-individual variation of serologic inflammatory biomarkers.

Authors:  Heather S McKay; Joseph B Margolick; Otoniel Martínez-Maza; Joseph Lopez; John Phair; Giovanna Rappocciolo; Thomas N Denny; Larry I Magpantay; Lisa P Jacobson; Jay H Bream
Journal:  Cytokine       Date:  2016-12-09       Impact factor: 3.861

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.